Results for “ ”

Entry Author Date Location
Oncorus Adds $79.5M to Steer Cancer-Fighting Virus to Human Testing 08/21/19 Boston
Elanco’s $7.6B Deal With Bayer Bolsters Pets, Farm Animals Footprint 08/20/19 Indiana
FDA Rejects Sarepta’s Second Duchenne Drug, Citing Safety Concerns 08/19/19 Boston
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs 08/16/19 New York
Bio Roundup: Zolgensma Fallout, Duchenne Redux, Ebola Boost & More 08/16/19 National
Will Porsche Fans Ever Live in a Driverless World? Porsche Says No. 08/16/19 San Francisco
Four New Drugs Are Around the Corner. Here’s What You Need to Know. 08/15/19 National
After Drought, Digital Health’s Summer of IPOs Brings Validation 08/14/19 National
Mason Raises $25M to Help Software Firms Deploy, Manage Applications 08/14/19 Seattle
Bio Roundup: Surprise News, a Gene Therapy Mess & a CAR-T Step 08/09/19 National
Bayer Buys Out BlueRock, Betting at Least $240M More on Cell Therapy Work 08/08/19 Boston
FDA: Despite “Manipulated” Data, $2M Gene Therapy Should Stay on Market 08/06/19 National
Another Delay for Intra-Cellular as FDA Extends Review of Psych Drug 08/05/19 New York
GlycoMimetics Sickle Cell Drug Flops as Others Creep Forward 08/05/19 New York
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More 08/02/19 National
Amicus Offers First Look At Gene Therapy Work With Batten’s Data 08/01/19 New York
White House Floats Canadian Import Plan But Excludes Many Costly Drugs 07/31/19 National
Mark Levin Named Xconomy’s 2019 Lifetime Achievement Award Winner in Boston 07/31/19 National
Upjohn & Mylan to Merge, Freeing Pfizer to Focus on Biopharma R&D 07/29/19 New York
Merck Data Are Another Step for Immunotherapy in Breast Cancer 07/29/19 New York
Duchenne Advocates Start Casimir, Aiming to Capture Missing Data 07/26/19 Boston
Bio Roundup: Leiden’s Exit, Depression Data, a New Pricing Bill & More 07/26/19 National
No Co-Founder? Y Combinator Offers Matchmaking at Startup School 07/26/19 San Francisco
As Castle Bio Jumps on IPO Train, Industry Trends Suggest Slowdown 07/25/19 National
Bristol, With Another Lung Cancer Flop, Loses More Ground to Merck 07/24/19 New York
Freenome Snags $160M to Boost Blood Test for Early Cancer Detection 07/24/19 San Francisco
TScan Lands $48M for Better, Safer T-Cell Receptor Cancer Therapies 07/24/19 Boston
With Regulator’s Nod, Bosch Plans Spread of Driverless Valet Parking 07/23/19 San Francisco
Could Facebook’s Crypto Break Financial System? Congress Airs Fears 07/19/19 San Francisco
Bio Roundup: Opioid Exposé, Gilead’s Gambit, Life Science IPOs & More 07/19/19 National
Page 2 of 148 « previous page · next page »